{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T20:49:15Z","timestamp":1778791755971,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["109-2320-B-038-032 -"],"award-info":[{"award-number":["109-2320-B-038-032 -"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2811-B-038-541 -"],"award-info":[{"award-number":["110-2811-B-038-541 -"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2320-B-038-020-MY3"],"award-info":[{"award-number":["110-2320-B-038-020-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.lfs.2022.120992","type":"journal-article","created":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T02:48:05Z","timestamp":1663901285000},"page":"120992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["The PDE5 inhibitor, vardenafil, ameliorates progressive pathological changes in a focal segmental glomerulosclerosis mouse model"],"prefix":"10.1016","volume":"309","author":[{"given":"Su-Wei","family":"Hu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Hung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhy-Shrian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yea-Mey","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Chang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Wen","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.lfs.2022.120992_bb0005","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","volume":"12","author":"Rosenberg","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"issue":"12","key":"10.1016\/j.lfs.2022.120992_bb0010","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41581-019-0217-5","article-title":"Molecular stratification of idiopathic nephrotic syndrome","volume":"15","author":"Saleem","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"issue":"6","key":"10.1016\/j.lfs.2022.120992_bb0015","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/ki.1985.225","article-title":"Focal segmental glomerular sclerosis - the cellular lesion","volume":"28","author":"Schwartz","year":"1985","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.lfs.2022.120992_bb0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-015-1821-9","article-title":"Podocyte and endothelial injury in focal segmental glomerulosclerosis: an ultrastructural analysis","volume":"467","author":"Taneda","year":"2015","journal-title":"Virchows Arch."},{"issue":"1","key":"10.1016\/j.lfs.2022.120992_bb0025","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrology"},{"issue":"1","key":"10.1016\/j.lfs.2022.120992_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2125.1993.tb05662.x","article-title":"Isoenzyme selective phosphodiesterase inhibitors: potential clinical uses","volume":"35","author":"Hall","year":"1993","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"20","key":"10.1016\/j.lfs.2022.120992_bb0035","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1074\/jbc.274.20.13729","article-title":"Cyclic GMP phosphodiesterase-5: target of sildenafil","volume":"274","author":"Corbin","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"9130","key":"10.1016\/j.lfs.2022.120992_bb0040","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0140-6736(97)91037-0","article-title":"Viagra's licence and the internet","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"19","key":"10.1016\/j.lfs.2022.120992_bb0045","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1056\/NEJMct0904473","article-title":"Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension","volume":"361","author":"Archer","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.lfs.2022.120992_bb0050","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.eururo.2018.10.014","article-title":"Antifibrotic synergy between phosphodiesterase type 5 inhibitors and selective oestrogen receptor modulators in Peyronie's disease models","volume":"75","author":"Ilg","year":"2019","journal-title":"Eur. Urol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120992_bb0055","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ijcard.2014.01.102","article-title":"PDE5 inhibitor sildenafil in the treatment of heart failure: a meta-analysis of randomized controlled trials","volume":"172","author":"Zhuang","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.lfs.2022.120992_bb0060","article-title":"Jole Fioritoa, Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer\u2019s disease","volume":"176","author":"Elisa Zuccarelloa","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.lfs.2022.120992_bb0065","article-title":"Phosphodiesterase-5 inhibition attenuates early renal ischemia-reperfusion-induced acute kidney injury: assessment by quantitative measurement of urinary ngal and kim-1","volume":"28","author":"Sohotnik","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.lfs.2022.120992_bb0070","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10157-021-02051-6","article-title":"Reno-protective effects of Phosphodiesterase 5 inhibitors","volume":"25","author":"Ozkan","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120992_bb0075","first-page":"R1146","article-title":"Nitric oxide synthase and cGMP-mediated stimulation of renin secretion","volume":"281","author":"Sayago","year":"2001","journal-title":"Am. J. Phys. Regul. Integr. Comp. Phys."},{"issue":"1","key":"10.1016\/j.lfs.2022.120992_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/HYPERTENSIONAHA.113.01291","article-title":"Renal collecting duct NOS1 maintains fluid-electrolyte homeostasis and blood pressure","volume":"62","author":"Hyndman","year":"2013","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.lfs.2022.120992_bb0085","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/ndt\/gfs391","article-title":"Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes","volume":"28","author":"Fang","year":"2013","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.lfs.2022.120992_bb0090","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1007\/s11255-015-1099-5","article-title":"Sildenafil activates antioxidant and antiapoptotic genes and inhibits proinflammatory cytokine genes in a rat model of renal ischemia\/reperfusion injury","volume":"47","author":"Zahran","year":"2015","journal-title":"Int. Urol. Nephrol."},{"issue":"3","key":"10.1016\/j.lfs.2022.120992_bb0095","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2249.2011.04483.x","article-title":"Sildenafil treatment attenuates lung and kidney injury due to overproduction of oxidant activity in a rat model of sepsis: a biochemical and histopathological study","volume":"166","author":"Cadirci","year":"2011","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120992_bb0100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/tox.22496","article-title":"The natural compound 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d glucoside protects against adriamycin-induced nephropathy through activating the Nrf2-Keap1 antioxidant pathway","volume":"33","author":"Lin","year":"2018","journal-title":"Environ. Toxicol."},{"issue":"4","key":"10.1016\/j.lfs.2022.120992_bb0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116700","article-title":"Glomerular endothelial cell injury and focal segmental glomerulosclerosis lesion in idiopathic membranous nephropathy","volume":"10","author":"Morita","year":"2015","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lfs.2022.120992_bb0115","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000508099","article-title":"Focal segmental glomerulosclerosis: state-of-the-art and clinical perspective","volume":"144","author":"Shabaka","year":"2020","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.lfs.2022.120992_bb0120","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11745-998-0192-z","article-title":"Hepatic cholesterol metabolism in experimental nephrotic syndrome","volume":"33","author":"Al-Shurbaji","year":"1998","journal-title":"Lipids"},{"issue":"3\u20134","key":"10.1016\/j.lfs.2022.120992_bb0125","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/hmg\/ddab022","article-title":"APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis","volume":"30","author":"Ge","year":"2021","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.lfs.2022.120992_bb0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nrneph.2014.87","article-title":"Lipid biology of the podocyte\u2013new perspectives offer new opportunities","volume":"10","author":"Fornoni","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120992_bb0135","first-page":"12","article-title":"Effect of long-term administration of sildenafil on lipid profile and organ functions in hyperlipidemic rats","volume":"84","author":"El-Mahmoudy","year":"2013","journal-title":"Acta Biomed."},{"issue":"5","key":"10.1016\/j.lfs.2022.120992_bb0140","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1681\/ASN.2015080885","article-title":"Sildenafil prevents podocyte injury via PPAR-gamma-mediated TRPC6 inhibition","volume":"28","author":"Sonneveld","year":"2017","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.lfs.2022.120992_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/path.4692","article-title":"The isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy","volume":"239","author":"Li","year":"2016","journal-title":"J. Pathol."},{"issue":"1","key":"10.1016\/j.lfs.2022.120992_bb0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.kint.2019.08.036","article-title":"Glycogen synthase kinase 3beta hyperactivity in urinary exfoliated cells predicts progression of diabetic kidney disease","volume":"97","author":"Liang","year":"2020","journal-title":"Kidney Int."},{"issue":"4","key":"10.1016\/j.lfs.2022.120992_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141848","article-title":"Age-related GSK3beta overexpression drives podocyte senescence and glomerular aging","volume":"132","author":"Fang","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"43","key":"10.1016\/j.lfs.2022.120992_bb0160","doi-asserted-by":"crossref","first-page":"29572","DOI":"10.1074\/jbc.M801547200","article-title":"Protein kinase G-dependent cardioprotective mechanism of phosphodiesterase-5 inhibition involves phosphorylation of ERK and GSK3beta","volume":"283","author":"Das","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2022.120992_bb0165","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1053\/j.ackd.2014.05.009","article-title":"The pathogenesis of focal segmental glomerulosclerosis","volume":"21","author":"Jefferson","year":"2014","journal-title":"Adv. Chronic Kidney Dis."},{"issue":"5","key":"10.1016\/j.lfs.2022.120992_bb0170","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.ijir.3901454","article-title":"The effect of vardenafil on endothelial function of brachial and cavernous arteries","volume":"18","author":"Mazo","year":"2006","journal-title":"Int. J. Impot. Res."},{"issue":"1","key":"10.1016\/j.lfs.2022.120992_bb0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10557-020-06939-5","article-title":"The Phosphodiesterase-5 inhibitor vardenafil improves the activation of BMP signaling in response to hydrogen peroxide","volume":"34","author":"Mao","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"issue":"10","key":"10.1016\/j.lfs.2022.120992_bb0180","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/1933719115574340","article-title":"Drug repositioning for preeclampsia therapeutics by in vitro screening: phosphodiesterase-5 inhibitor vardenafil restores endothelial dysfunction via induction of placental growth factor","volume":"22","author":"Kakigano","year":"2015","journal-title":"Reprod. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2022.120992_bb0185","doi-asserted-by":"crossref","first-page":"F1174","DOI":"10.1152\/ajprenal.00320.2007","article-title":"Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis","volume":"294","author":"Campean","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"issue":"2","key":"10.1016\/j.lfs.2022.120992_bb0190","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1681\/ASN.V132544","article-title":"Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor","volume":"13","author":"Satchell","year":"2002","journal-title":"J Am Soc Nephrol"},{"issue":"5322","key":"10.1016\/j.lfs.2022.120992_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.277.5322.55","article-title":"Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis","volume":"277","author":"Maisonpierre","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.lfs.2022.120992_bb0200","first-page":"408","article-title":"Kidney outcome in primary focal segmental glomerulosclerosis (FSGS) by using a predictive model","volume":"15","author":"Ossareh","year":"2021","journal-title":"Iran J. Kidney Dis."},{"issue":"2","key":"10.1016\/j.lfs.2022.120992_bb0205","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.urology.2006.05.011","article-title":"Vardenafil prevents fibrosis and loss of corporal smooth muscle that occurs after bilateral cavernosal nerve resection in the rat","volume":"68","author":"Ferrini","year":"2006","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.lfs.2022.120992_bb0210","first-page":"L24","article-title":"PDE5A inhibition attenuates bleomycin-induced pulmonary fibrosis and pulmonary hypertension through inhibition of ROS generation and RhoA\/Rho kinase activation","volume":"294","author":"Hemnes","year":"2008","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522006920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320522006920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:45:29Z","timestamp":1777423529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320522006920"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":41,"alternative-id":["S0024320522006920"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120992","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The PDE5 inhibitor, vardenafil, ameliorates progressive pathological changes in a focal segmental glomerulosclerosis mouse model","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2022.120992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120992"}}